Thorne Acquired by Procter & Gamble in Definitive Agreement
Thorne, a leading provider of science-backed health and wellness solutions, has announced its acquisition by Procter & Gamble (NYSE: PG) in a definitive agreement. The deal positions Thorne to continue advancing its mission of becoming the world's most trusted personalized health brand.
Founded in 1984, Thorne has built a reputation as a trusted partner to healthcare practitioners and a leader in science-backed health solutions. With its rigorous approach to research, quality manufacturing, and uncompromising standards, Thorne serves consumers, athletes, and healthcare professionals worldwide.
The acquisition by P&G will enable Thorne to expand its impact while remaining true to its values and standards. Paul Gama, CEO of P&G's Health Care business, stated that the deal strengthens their position in premium wellness with a trusted, science-backed brand that complements their existing portfolio.
The transaction is expected to close later this year, subject to customary closing conditions and regulatory approvals.